Adcytherix gains $122m to propel ADC development
Adcytherix has set a target to file for an IND and clinical trial applications in Canada, the UK, and the EU by the end of 2025.
Adcytherix has set a target to file for an IND and clinical trial applications in Canada, the UK, and the EU by the end of 2025.